Cytosorbents Corporation ( CTSO) - Key Metrics
CTSO Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $0.15 | -$0.09 | ? | ? |
| 2025Q3 | $0.15 | -$0.05 | -$0.04 | -$0.04 |
| 2025Q2 | $0.15 | $0.03 | -$0.02 | -$0.02 |
| 2025Q1 | $0.14 | -$0.02 | -$0.06 | -$0.06 |
CTSO Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | ? | -1.83 |
| 2025Q3 | ? | -4.62 |
| 2025Q2 | ? | 10.29 |
| 2025Q1 | ? | -10.27 |
CTSO Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | -3.30% | ? |
| 2025Q4 | -12.18% | ? |
| 2025Q3 | -4.43% | ? |
| 2025Q2 | -1.93% | ? |
| 2025Q1 | -5.78% | ? |
CTSO
Price: $0.36
52 week price:
Payout Ratio Range:
Earnings Per Share: -0.19 USD
Exchange: NCM
Sector: Healthcare
Industry: Medical Devices
Country: United States
Volume: 305200
Ebitda: -2.1 millionMarket Capitalization: 27.0 million